KCT0000356招募中未知
Application of double filtration plasmapheresis(DFPP) in reducing the risks of metabolic syndrome
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 20(Year) 至 65(Year)（—）
- 性别
- All
入选标准
- •The subjects who are 20-65 aged, spontaneously consent this study and put their signature on the consent form, have diagnosis of metabolic syndrome, and are relevant below 2 of 3 matters
- •1) Homocysteine >= 11.5 umol/L
- •2) Fibrinogen >= 200 mg/dL
- •3) Hs-CRP > 1.0
排除标准
- •1)severe complications such as liver failure, heart failure, diseases related to blood.
- •2)pregnant
- •3)body weight <= 45 kg
- •4)shock events
- •5)bleeding tendency
- •6)Lipid abnormality caused by hypothyroidism, Cushing syndrome, obstructive bile duct disease, lupus, pancreatitis, malignant lymphoma or nephrosis
- •7)communcation disability
- •8)recent blood donation
研究者
相似试验
招募中
不适用
Application of double filtration plasmapheresis(DFPP) in reducing the risks of SLEDiseases of the blood and blood -forming organs and certain disorders involving the immune mechanismKCT0000346Seoul National University Hospital12
Unknown
1 期
Double Filtration Plasmapheresis Combined With ChemotherapyMultiple MyelomaNCT04836871Fuling Zhou20
已完成
不适用
COMbining Plasmafiltration and Adsorption Clinical Trial: efficacy and safety of coupled plasma filtration adsorption for septic shock in the intensive care unitInfections and InfestationsOther septicaemiaSeptic shockISRCTN24534559Italian Group for the Evaluation of Interventions in Intensive Care Medicine (GiViTI)330
终止
不适用
The Clinical Efficacy of DFPP in Patients With AAGNAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisNCT02294344Zhi-Hong Liu, M.D.14
招募中
3 期
Effectiveness of Plasmaphersis on the treatment of paraquat poisoned patientsIRCT20200507047344N4Esfahan University of Medical Sciences80